title: The challenge of Bacillus Calmette-Guérin failure in nonmuscle invasive bladder cancer--what is the next step in management?
authors.forename: Yair
authors.initials: Y
authors.lastname: Lotan
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology; D015653:Cystectomy / Q000379:methods; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy*; D018579:Patient Selection; D011379:Prognosis; D019233:Retreatment; D017211:Treatment Failure; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D001500:BCG Vaccine